The FDA has agreed to take MDMA, also known as "Molly," into large-scale Phase 3 clinical trials. That is the final step before the drug can be approved for clinical use. This has been great news for the people working towards using psychedelics in a beneficial way.
A 2015 study showed that the drug could have positive psychotherapeutic effects on autistic adults. Better yet, the paper states that, unlike antidepressants like Zoloft, there is no need to take daily dosages of MDMA to feel the positive effects.
The promise of MDMA legalization has already made an impact on those who were part of the MDMA trials. C.J. Hardin, a US veteran from Iraq and Afghanistan, was a hermit alcoholic with suicidal episodes because of his PTSD. After joining the drug trial in 2013, he now goes to college and works as an airplane mechanic.
7. The Other Three-Letter Department That Can Change Things
Another federal agency, the DEA, might help in legalizing psychedelics like MDMA. Due to drug scandals in the department, the head of the agency resigned, easing the tough stance the DEA has had on many drugs, including MDMA. With the Trump administration that may be an issue again, however.
The DEA still considers MDMA a Schedule I substance — meaning it is still illegal — but there are outside groups trying to change that. One of them is the Multidisciplinary Association for Psychedelic Studies, or MAPS, a non-profit with the goal of speeding up MDMA legalization. They are doing that through funding research, buying hundreds of thousands of pure MDMA and recruiting hundreds of patients for testing.
MAPS was even given the chance to talk to the Pentagon about legitimizing MDMA for therapeutic use. The reason was to see if clinical trials that would help the military would be allowed. Rick Doblin, the founder of MAPS, said that it was a great sign of progess that the military was considering that option.
It should be noted that MDMA is not a cure for PTSD; it merely assists in the psychotherapy sessions. There would be a few non-drug sessions between the patient and therapist to develop a relationship. Then there are the sessions where the patient talks about the traumatic events after MDMA was administered to them.
If the 2017 trials go well then MDMA can be ready for clinical use by 2021. Charles Marmar, a PTSD researcher from NYU's Langone School of Medicine, said that if good results can be found then it will show it can be a new treatment for a very hard condition. Current therapies at the time are not effective for up to 40 percent of PTSD patients.
12. Making It Legal Here Might Help Across The Pond, Too
When MDMA becomes legal in the states, it can bring pressure to legitimize it in other countries. In the UK, it would help in reducing the number of deaths from the impurity of Molly bought on the street. MAPS has also performed studies in countries like Spain and Israel regarding PTSD treatment using MDMA.
13. Of Course, Always Remember These Tips On Molly
MDMA on its own has plenty of dangers to consider, with the most common being terrible impurity. The threat of dehydration and when the "come-down" will come arrive — maybe the loss of serotonin or other external factors — also makes this a substance that might not be the best choice for an anxiety medication. Always talk to a professional before you decide if it is a good idea to take the risk on your own.